Healthcare Companies in Europe

Science has confirmed the multifactorial origin in hair loss and its relationship with health and lifestyle. In Olistic we offer a modern approach to tackle all 6 causes in a single shot made of natural and vegan ingredients. We create clinically effective solutions for hair growth and hair care, providing support for people at every step of their hair journey. Our multi-factorial approach targets the 6 root causes of hair thinning using a science backed and medical-grade products. We are committed to growth, help people achieve their best version of themselves is our main motivation and we want to empower you with our passionate view for innovation, growth and wellness.

Exeter Analytical (UK) Ltd is a leading elemental analysis specialist based in Coventry, West Midlands. For over 30 years, we’ve provided precision ICP-OES testing, CHN analysis, and expert technical support to a diverse range of industries, including pharmaceuticals, polymers, and battery technology.

We support laboratories, research institutions, and industrial clients worldwide with a complete suite of analytical services. Our commitment to quality is backed by rigorous standards and a dedication to fast, accurate results.

Exeter Analytical offers a comprehensive range of solutions, from initial method development and method validation to external quality control testing and bespoke training. We pride ourselves on our unmatched application support and decades of experience, ensuring our clients receive the precise results they need.

C2-Ai is a Cambridge-based AI solutions provider specializing in healthcare analytics and patient tracking systems. We leverage over 30 years of research and a substantial patient dataset – over 450 million records – to deliver globally unique AI-backed tools for hospitals.

Our core mission is to demonstrably reduce avoidable harm, mortality, and variation within healthcare settings, while simultaneously generating significant cost savings for hospitals.

C2-Ai’s Compass Ai-backed tools support evidence-based clinical decision making, assessing and stratifying patients early and proactively treating them based on their individual risk levels. We offer solutions that don't require complex integration or internet connectivity, delivering impactful results quickly and efficiently.

We empower hospitals to improve patient outcomes, optimize resource allocation, and enhance operational efficiency – ultimately saving hundreds of thousands of lives and reducing clinical negligence claims.

Cryos International is a leading international sperm and egg bank, headquartered in Denmark, dedicated to helping individuals and families worldwide realize their dream of parenthood.

For over 30 years, Cryos has been at the forefront of donor gamete provision, offering a vast selection of ethically sourced and rigorously screened sperm and egg donors representing diverse ethnicities and phenotypes. We connect patients with a world-leading selection of donors, ensuring access to high-quality frozen donor sperm and donor egg embryos for fertility treatments both domestically and internationally.

Cryos International operates with a commitment to quality, compliance, and patient safety, holding certifications including ISO 9001:2015 and adhering to stringent regulations across multiple countries. Our experienced team provides personalized guidance and support throughout the entire process, from donor selection to treatment coordination. We are the world’s largest sperm and egg bank, distributing to over 100 countries and empowering countless families to build their futures.

ESPINEA® is a Karlsruhe, Germany-based Endoscopic Spine Academy dedicated to advancing minimally invasive spinal surgery techniques.

We provide a globally-recognized training and education program for spine surgeons, leveraging the joimax® endoscopic systems. Our mission is to support professionals in delivering the highest standard of patient care through evidence-based knowledge and hands-on experience.

ESPINEA®’s training standards are clearly defined, catering to both beginner and experienced surgeons seeking to deepen their expertise in endoscopic spinal therapy. We are accredited by the Royal College of Surgeons of Edinburgh and operate through a network of international chapters, fostering a collaborative community of spine specialists.

Cell-Easy developed a unique vision of CDMO dedicated to the production of Cell-based Therapy products, this integrated concept is called CDMAO. Beyond conventional CDMO, Cell-Easy is not only focusing on Development & Manufacturing but we are positioning as a real partner for helping Biotech & Pharma to bridge the gap between preclinical and clinical development with in depth expertise on regulatory process scale-up and analytics. Cell-Easy offers customized process development, process scale-up, cGMP manufacturing and unique analytical services for immune cells (engineered CAR-T, NK, …cells, and non-engineered cells) and adult stem cells (MSCs, iPSCs and Exosomes) in both Immuno-Oncology and Regenerative Medicine fields. Cell-Easy is a trusted partner and brings today the infrastructure and know-how while ensuring your projects are delivered on time and budget. Supported by highly motivated and experienced people in the Cell Therapy field, Cell-Easy is committed to driving service excellence and actively contribute to a “Bench to Bedside” culture, putting the health care of patients at the heart of everything.

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having achieved animal in-vivo proof of concept for several new targets. Cellestia was founded in 2014 as a spin-off from EPFL, Lausanne, Switzerland and is headquartered in Basel, Switzerland.

We provide the AI tools for the analysis of brain function in intensive care. CERENION C-TREND™ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated technology can be integrated into EEG-measurement devices and patient monitors as a software feature. CERENION C-TREND™ is a medical-grade software solution that works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The result is a set of easy parameters that aid medical professionals in clinical decision making. The patented technology has the potential of improving both the quality and the cost of intensive care. Cerenion™, Cerenion C-Trend™, C-Trend™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. All rights reserved. © Cerenion Oy 2017.

HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing a pipeline of lncRNA-targeting candidates for the cell-specific treatment of diseases in other tissues, including the lungs and the microenvironment of solid tumor cancers. Headquartered at the life sciences park Biopôle in Lausanne, Switzerland with laboratory facilities at JLABS @ San Diego, HAYA is led by a world-class team of experts in programmable and precision RNA-targeted therapeutics and is supported by a strong investor consortium. HAYA’s mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than existing treatments.

AMPLY Discovery is a drug and nutraceutical discovery company based in Northern Ireland. A spin-out company from Queen's University Belfast, we use machine learning and AI to discover new therapeutic molecules for hard-to-treat diseases. This includes developing new drugs to replace conventional antibiotics and help tackle AMR. Our discovery platform is designed to mine vast biological datasets in silico and validate hundreds of hits in vitro.

Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Our mission is to develop a new drug to treat Glioblastoma Multiforme. We aim to significantly increase life expectancy for patients, improve patient comfort, and generally increase the overall survival rates for GBM patients.

HERA-MI brings AI to improve breast cancer early detection to increase recovery rate and to optimize healthcare treatment for women. Breast Cancer is one of the leading cancer causes among women. However, when diagnosed early, patient can recover in almost 90% of cases. HERA-MI is developing a clinical decision support system based on machine learning and medical imaging processing that will improve breast cancer early detection. The system will enhance diagnosis quality and accuracy while reducing radiologists interpretation time. Moreover HERA-MI solution focuses on patient care improvement. With the more efficient breast cancer screening it allows women to be treated earlier and thus offers them higher chances for recovery.

This is Higo® – a breakthrough telemedical solution, that introduces a new definition of "medical appointment". Doctors no longer have to take patients in the office, because – thanks to Higo® – patients can collect data about their health themselves: measure temperature, listen to the heart and lungs, take pictures of the throat, ear and skin. Afterwards, Higo sends the data to the doctor who makes the diagnosis.

Hintsa is the world’s leading, evidence-based coaching company, helping top athletes and business professionals achieve sustainable success. Driven by science and guided by people, our methods are road tested in the world’s most challenging business and sports environments. Formula 1 Champions, Fortune 500 CXOs, leading management consultancies, non-profit crisis workers, surgeons, and power plant workers all trust Hintsa to help them live better and perform better. We are proud to be recognised as a thought leader in our field by the World Economic Forum and McKinsey Quarterly.

We are a precision medicine pioneer in psychiatry based in Munich. Founded in 2010, our privately held biotech company combines the development of machine learning-enabled companion diagnostics with specific therapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. Our ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. We strives to reduce not only the immense individual burden, but also the societal impact of these diseases. We develop patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.

Lifen develops operating systems for the healthcare sector that aim to positively reshape the key components of interoperability, data security, reliability, and compliance standards for digital health. Using the best Artificial Intelligence has to offer, we craft and train algorithms that reliably and automatically structure and integrate health information for a truly complete and dependable system of record that allows for more informed decision-making and diagnosis. Our interoperability platform also simplifies market access for digital health applications worldwide, thanks to API connectors that enable third-party application data to connect to any IT infrastructure. We are a team of 160+ Lifeners based in France and Germany, fully committed to bringing the best of the digital revolution to the healthcare sector!

At Hublo, we are strong believers in the power of tech for healthcare and we look forward to putting our energy and resources at the service of this much needed transformation. We dream about a world where patients could be taken care of and cured to the maximum of what is humanly possible. Realising such a vision requires to create an optimal work environment for caregivers who are the cornerstone of the healthcare system. This is precisely our mission, by digitising time-consuming manual processes and making them fast and intuitive, we free up precious time for caregivers, which they can spend taking care of patients. In 2016, we launched our first product: a short-term staffing management solution for healthcare facilities to save time, reduce recruitment costs and improve their employer-employee relationships. As of today, Hublo is used by over 500,000 healthcare professionals. The solution has helped manage 55 million replacement hours in more than 2,500 healthcare facilities in France. In 2021, we also launched Hublo in Germany where healthcare staff management is also the number one challenge for hospitals. Would you like to know what our customers think? https://youtu.be/ODYvLdOLUAg The Hublo team is now rich of 130 talents, the "Hublees", who work every day to best serve the needs of hospitals and nursing homes. You want to contribute to this mission? Join us! https://careers.hublo.com The adventure has just begun!

The world’s first evidence-based training system designed to significantly improve everybody’s hand hygiene, showcase quality improvement, and reduce the risk of spreading infectious diseases.

In response to the increasing challenge facing the healthcare sector, a group of renowned scientists, medical doctors, entrepreneurs and academic figures is launching a unique endeavour: healthbank. At healthbank we are building the world’s first people-owned health data transaction platform. healthbank will connect data sources from all facets of the healthcare ecosystem and reward participants for sharing their data for research purposes. Based in Switzerland, healthbank will leverage the advantages of Swiss neutrality, trust, and data privacy to enable users, researchers, and organisations with large data sets, to unlock the value of health and medical data on our independent, global transaction platform. healthbank is organised as a Swiss Cooperative that is fully owned and governed by its members. Its purpose is to empower users to store, access, manage and share and gain returns from their personal health information according to their needs. Our vision is to play an active role in raising people’s awareness of health beyond illness, by providing self-governed, user-centric participative platforms and value-added services that enable health data accessibility, protection and rewards.

Healthera is a rapidly growing health tech company. It is a healthcare platform that provides patients with medicines, services and products through the largest digital network of pharmacies in the U.K. We work with over 1,500 pharmacies with a reach of over 30 million patients, including national chains and local branches. We provide patients with transparency on personal medication management and access to the fastest medicine delivery available.

We believe that everyone affected by hearing loss should have access to care. For this to happen, diagnosing hearing loss needs to be made easy and reliable. Our mission is to achieve this by developing an innovative new screening device.

Heart Force is about to break new ground in the early detection of heart disease. Through the assessment of the cardiac performance with a new unique technology we are able to detect coronary artery diseases at an early stage. Our Cardiac Performance Metrics represent a new capability for analyzing cardiac timing, rhythm and strength not found in the personal monitoring and screening space. Cardiovascular disease (CVD) is the number one cause of death globally (Source: WHO). Early detection is the missing key to successfully combat CVD, but difficult to achieve; CVD often does not show any symptoms. Through Heart Force it will be possible to self monitor the overall heart health and spend a life with more clarity concerning the overall heart health.

In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry. We currently focus on a long existing problem in hatcheries: The culling of one day old male chickens. Our solution, a gender screening in the first half of the breeding process, has several advantages. It prevents a lot of stress the chickens experience during the current manual gender sorting process, it reduces the energy consumption and CO2 emission of the hatchery and prevents the need to kill one day old chickens. This way, we make hatcheries more animal friendly and sustainable, and increase the efficiency at the same time.

Incision is a fast-growing platform for improving surgical performance and online training — with the mission to connect surgical professionals to what they need and help them find their personal best. Our “digital assistant” — a mobile app, helps members of the surgical team to learn visually, prepare, and align with one another on their daily work. We believe in sharing surgical skills and making high-quality surgical knowledge available to everyone. That's why we created Incision — to enable continuous surgical improvement that leads to better outcomes for everyone. We partner with leading clinics, societies and hospitals around the world to deliver the most accurate and high-quality content and services. Our continued strategic focus on product leadership has been rewarded with accreditations and endorsements from renowned international institutes like the Royal College of Surgeons, ESSO, EHS-GREPA, ASGBI, LVO, and NVAM. We have a Shareholder Board with esteemed surgeons and medical entrepreneurs and a Medical Advisory Board with renowned international surgeons including Jaap Bonjer and David Farley. Every day, we’re searching for new ways to support the efforts of the surgical team and make their challenging work run more smoothly. It's our vision to be the digital assitant of surgical professionals worldwide and the technology that supports that effort. Our dream is to impact 100 million procedures each year in 2030, connecting 10.000 clinics and millions of surgical professionals to what they need.

InFlectis BioScience is a private clinical stage company aiming at targeting and modulating interactions between proteins involved in key human pathophysiological processes. The company is developing small molecule drugs that specifically target the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of disease affecting the central nervous system (CNS), peripheral nervous system (PNS) and inflammation.

𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐧𝐲𝐭𝐢𝐦𝐞 is the #1 health tech multinational company to search for medical services. Founded in 2012 we are already operating in 6 countries. ▪️ We are an innovative platform that improves all functional/management matters of healthcare, like finding the right doctor for a user, booking appointments, creating and keeping a medical file etc. ▪️ Everyday we help hundreds of people to find the right doctor, the medical examination they need and book an online appointment with the selected doctor immediately. Setting as our main objective to respond to one simple need: 𝐭𝐨 𝐜𝐮𝐫𝐞 𝐚𝐧𝐝 𝐜𝐚𝐫𝐞, to offer anyone the security and peace of mind, when it comes to health related issues. ▪️ 𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐧𝐲𝐭𝐢𝐦𝐞 is free for patients and available in: - Greece - Belgium - Cyprus - Mexico - Argentina - Brazil - Peru - Ecuador - Colombia with many more soon to come.

At doctorly we are creating the future of digital health care. Our vision: 'Enabling people to live healthier lives'. We believe that technology, hand in hand with medical professionals, can create a truly modern and exponentially more effective approach to health care. With our unique b2b2c model, doctorly provides all of the digital technology, tools, and support, via a single system, for a doctor to efficiently and digitally manage their practice, and to engage with their patients like never before. We are also enabling patients to access, control and understand their own health records and data. Backed by some of the best investors in the world, the doctorly team is a wonderful mix of serial tech-entrepreneurs, amazing engineers & medical experts. We're hiring: https://doctorlycareer.kenjo.io/

Our mission is to create a comprehensive, patient-centric ecosystem that empowers individuals and healthcare professionals alike through a unique digital health platform to bring more quality of life for everyone.

BDD Pharma combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report. We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.

Dudyfit is now HARBIZ ❤️‍🔥 We've evolved to remain the #1 app for fitness & wellness professionals. We're a client and service management platform for professionals - more than 4000 already! We help these professionals to digitize their businesses by increasing engagement, and revenue and making them scalable. We do this by unifying all the functionalities of the tools they currently use, i.e., WhatsApp, email, word, excel, bank transfers, skype, pen, and paper... All of this is integrated into a single platform minimizing the time spent on these management tasks, and providing traceability and analytics of all data collected from each client, thus professionalizing their services and their way of working.

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.

Susu's mission is to make healthcare affordable and accessible for Africans, in an integrated approach which connects the beneficiaries of the services, their families, and healthcare professionals. - Our services include care bundles which are packages of curative and preventative services designed to monitor the condition of chronic disease patients and pregnant women. - We also offer insurance services in partnership with insurance providers. - Our offers can be subscribed by African diaspora members on behalf of their loved ones back home

Ada is a global health company created by doctors to improve human health by transforming knowledge into better outcomes. Ada is the world's most popular symptom assessment app, with 10 million users and 25 million completed assessments. Every three seconds, someone turns to Ada for personal health guidance. Our powerful enterprise solutions help partners inform health decisions, triage to appropriate care, and reduce avoidable costs. We work with healthcare systems and providers, insurers, payers and commissioners, life sciences, employers, governments, and non-profits.

Biorelate helps scientists solving the most difficult biomedical challenges of today. We do this by curating truths from existing knowledge, enabling smarter and faster research & development.

bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.

IOMED has developed a Natural Language Processing tool that allows hospitals to structure their information identifying clinically relevant variables from medical notes and structuring them into datasets, which can then be easily queried. Thanks to this data structuration, professionals and researchers from the hospitals can access to the information stored in their facilities more quickly thus accelerating patient recruitment by reducing the time invested in this process. At the same time, it allows hospitals to improve the quality of their services. Overall, we accelerate Clinical Research through the use of Artificial Intelligence, allowing access to structured RWD from hospital medical records and considerably optimizing your studies in time and access to patient volume. Finally, data protection is IOMED’s priority and we work to ensure a safe and secure environment: each hospital decides and authorizes all data uses and participation in projects, the data is stored entirely within the hospital, and always following international and Spanish legislation.

iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development. Imprint: https://iomx.com/imprint

At Yoppie we’re building both digital and physical tools, services and products that enable today’s modern woman to take control of her menstrual health - starting with personalised eco friendly period care, PMS and condition supplements as well as hormonal skincare. We ultimately envision a world where women feel confident and empowered by their own unique menstrual cycle thanks to the removal of taboos, improved education and access to powerful subscription management tools. Check out our Full Stop Blog for answers to some of the most common menstrual health questions www.yoppie.com/blog

Jutro Medical’s advanced telemedicine platform and app offer virtual consultations, prescriptions, referrals, lab results and the ability to request medical leave online for less complex cases. Yet when more direct, more detailed or more complex care is required, patients can be seen by a Jutro Medical practitioner – typically the practitioner they’ve been liaising with virtually to maintain a continuity of care – at the startup’s proprietary clinics. All on the same day and all without waiting times, or having to constantly repeat their medical history and care needs with various people. This improves the experience for patients, gets them access to the best care possible, all while making doctors more productive.

Make Team Culture your Competitive Advantage. Upskill your Team Leaders to build more human teams with The Culture Academy - action focussed, cohort-based learning programmes. Learn more at https://kaido.org.

We took telemedicine to a whole new level. Invented the first Precision Medicine platform. And didn't survive the Covid-19 crisis. Thank you. We'll miss you.

B-Secur is a heart health technology company. Founded in Belfast, Northern Ireland, we are on a mission to save and improve millions of lives each year by advancing heart health technology that brings greater clarity to EKG interpretation with better data and deeper insights. We spent many years immersed in deep scientific research in EKG biometric security. This led us on a unique journey to develop heart health technology and drive better health outcomes for future generations. Covid-19 has accelerated the pace of our innovation as the world of medical technology and consumer devices converge. We have created HeartKey® 2.0, a suite of powerful EKG algorithms and analytics that enhances signal clarity, reduces signal noise, and delivers FDA-cleared health data with actionable wellness insights. We partner with world-leading technology companies reducing time to market for next generation medical and consumer devices and platforms. Our expertise in EKG coupled with deep experience in hardware, software and science enables our partners to tackle the fundamental healthcare issues of today.

Axial3D, a leader in medical segmentation and 3D printing, provides hospitals and medical device manufacturers access to an easy to use, fast, affordable way to transform 2D medical image data into 3D. Through our 510(k) cleared, cloud-based segmentation platform, we convert patients’ DICOM data into accurate and data rich 3D visualizations, printable files, and 3D models printed with Stratasys print technology in an efficient and scalable way. Our mission is to make patient-specific 3D solutions accessible to all, enabling surgeons, radiologists, and engineers the resources to improve patient outcomes and accelerate patient specific programs.

Neuroelectrics® is a digital brain health company that innovates at the intersection of neuroscience, physics, machine learning, and hardware. We have developed wireless EEG and tDCS/tACS/tRNS stimulation devices with up to 32 channels, amongst other products encompassing software and research services, with the purpose of monitoring and enhancing brain health.

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. The wide-ranging disease risk predictions provided by Nightingale consist of two interconnected factors: The extensive blood analysis technology developed by Nightingale and a large amount of data on health events. Nightingale helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone. We’re a team of 60 members––a diverse bunch with interdisciplinary expertise in business, marketing, computational medicine, data science, healthcare, IT, design and more––who envisage a world that focuses on keeping people healthy rather than just treating illnesses. So, if you are looking to enable good tech that could make a real difference, Nightingale is the place to be.

Innovation to patient, faster Platomics enables in vitro diagnostic manufacturers and laboratories to bring safe and effective innovations to market with unparalleled speed and efficiency. Our global platform for generating and marketing compliant IVD products is equipped with intelligent regulatory automation that allows our clients to seamlessly overcome regulatory challenges over the entire life cycle of their products.

Innovative polish company offering monitoring wristbands and telemedine platform to hospitals, institutions, idividuals SiDLY initiates the development of medical telematics in Poland and Europe. SiDLY sp.z o.o. as one of the first organizations, deal comprehensively with medical diagnostics from the distance, starting from the search of areas requiring initiating telematics solutions through design, testing and constructing of both- devices and systems, and the dedicated application. SiDLY team, consists of the representatives of technology, medicine and science. The products of SiDLY improve the work of clinics and houses of Social Welfare. They also enable a remote medical diagnostics for individual costumers. Telemedical platform with wristbands is implemented in hospitals, including contagious departures.

Pharmacy2U is the UK's first and largest online pharmacy. We're a market leader in the pharmacy world, helping over 750,000 patients in England manage their NHS repeat prescriptions from request through to delivery. For over 20 years, we have used cutting-edge technology alongside our UK-based pharmacists, dispensing specialists, and customer care advisers to help improve the lives of patients. Our Leeds and Leicester -based dispensing facilities distribute over 1 million medication items to patients across England every month. KPMG’s Customer Excellence report recently revealed Pharmacy2U is the UK’s number one brand for experience and value, based on a survey of over 10,000 UK consumers. This accolade cements our position as the nation’s go-to online pharmacy and keeps us committed to further broadening our healthcare offering. Our goal is to make simple and convenient healthcare accessible to all. As well as our repeat prescriptions service, patients can also access: - A one-stop online healthcare shop featuring over 4,000 products - Confidential online GP consultations for a range of conditions - Enhanced pharmacy services such as the NHS New Medicine Service We're an ambitious company with big plans and we're looking for talented individuals to join our team and help us to continue excelling in our field. Our CEO Kevin Heath says, “come and join a team that truly lives by our company values of putting the patient at the heart of everything we do”. Want to help shape the future of online healthcare in the UK? Discover our latest vacancies today.

Oncomfort Digital Sedation™ is a non-pharmacological therapy for relieving patients’ pain and anxiety before, during and after medical procedures. This digital therapy combines clinical hypnosis and integrative therapeutic techniques through Virtual Reality.

We are Germany's first purely digital health insurance company. Our mission is to finally make the complex topic of health insurance and healthcare simple and transparent. As a reliable healthcare partner, we help people stay healthy or become healthy. 100 % digital, 100 % human. In addition to private comprehensive health insurance and supplementary health insurance, ottonova's portfolio also includes software solutions for the insurance industry. Digital also means that we are, of course, personally available to our customers for questions and concerns, always just a click away. In this way, we want to give them more time for the life they want to live. That's why we are constantly developing our digital services. In 2022, ottonova was named the insurer with the highest customer satisfaction for the fourth time in a row in the KUBUS study of private health insurers. Our employees think: there are many reasons to work for us. They have voted us one of the best employers in Germany. Because our ottonova spirit makes us a "Great Place to Work: We work as a team, across locations, disciplines and career levels, and together we boldly break new ground and provide the necessary freedom for new impulses to make healthcare as innovative and effective as possible. ottonova has also been certified as a climate-neutral company since 2022. We are proud of that!